152 related articles for article (PubMed ID: 16570188)
1. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects.
Röshammar D; Hai TN; Friberg Hietala S; Van Huong N; Ashton M
Eur J Clin Pharmacol; 2006 May; 62(5):335-41. PubMed ID: 16570188
[TBL] [Abstract][Full Text] [Related]
2. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
Giao PT; de Vries PJ; Hung le Q; Binh TQ; Nam NV; Kager PA
Trop Med Int Health; 2004 Feb; 9(2):209-16. PubMed ID: 15040557
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
[TBL] [Abstract][Full Text] [Related]
5. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers.
Hai TN; Hietala SF; Van Huong N; Ashton M
Acta Trop; 2008 Aug; 107(2):145-9. PubMed ID: 18585670
[TBL] [Abstract][Full Text] [Related]
6. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
[TBL] [Abstract][Full Text] [Related]
7. Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
Kobylinski KC; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Pantuwatana K; Phasomkusolsil S; Davidson SA; Winterberg M; Hoglund RM; Mukaka M; van der Pluijm RW; Dondorp A; Day NPJ; White NJ; Tarning J
Clin Pharmacol Ther; 2020 May; 107(5):1221-1230. PubMed ID: 31697848
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Rijken MJ; McGready R; Phyo AP; Lindegardh N; Tarning J; Laochan N; Than HH; Mu O; Win AK; Singhasivanon P; White N; Nosten F
Antimicrob Agents Chemother; 2011 Dec; 55(12):5500-6. PubMed ID: 21947392
[TBL] [Abstract][Full Text] [Related]
9. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
Gerardin J; Eckhoff P; Wenger EA
BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
[TBL] [Abstract][Full Text] [Related]
10. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of piperaquine after single and multiple oral administrations in healthy volunteers.
Liu C; Zhang R; Hong X; Huang T; Mi S; Wang N
Yakugaku Zasshi; 2007 Oct; 127(10):1709-14. PubMed ID: 17917428
[TBL] [Abstract][Full Text] [Related]
12. The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.
Zang M; Zhu F; Zhao L; Yang A; Li X; Liu H; Xing J
Malar J; 2014 Dec; 13():478. PubMed ID: 25476790
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
Tarning J; Ashley EA; Lindegardh N; Stepniewska K; Phaiphun L; Day NP; McGready R; Ashton M; Nosten F; White NJ
Antimicrob Agents Chemother; 2008 Mar; 52(3):1052-61. PubMed ID: 18180343
[TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects.
Ahmed T; Sharma P; Gautam A; Varshney B; Kothari M; Ganguly S; Moehrle JJ; Paliwal J; Saha N; Batra V
J Clin Pharmacol; 2008 Feb; 48(2):166-75. PubMed ID: 18199893
[TBL] [Abstract][Full Text] [Related]
15. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
Reuter SE; Evans AM; Shakib S; Lungershausen Y; Francis B; Valentini G; Bacchieri A; Ubben D; Pace S
Clin Drug Investig; 2015 Sep; 35(9):559-67. PubMed ID: 26293519
[TBL] [Abstract][Full Text] [Related]
16. Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
von Seidlein L; Hanboonkunupakarn B; Jittamala P; Pongsuwan P; Chotivanich K; Tarning J; Hoglund RM; Winterberg M; Mukaka M; Peerawaranun P; Sirithiranont P; Doran Z; Ockenhouse CF; Ivinson K; Lee C; Birkett AJ; Kaslow DC; Singhasivanon P; Day NPJ; Dondorp AM; White NJ; Pukrittayakamee S
Hum Vaccin Immunother; 2020; 16(1):33-41. PubMed ID: 31306084
[No Abstract] [Full Text] [Related]
17. Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.
Chairat K; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Hanpithakpong W; Blessborn D; White NJ; Day NPJ; Tarning J
J Antimicrob Chemother; 2018 Nov; 73(11):3102-3113. PubMed ID: 30085149
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
Tarning J; Lindegardh N; Sandberg S; Day NJ; White NJ; Ashton M
J Pharm Sci; 2008 Aug; 97(8):3400-10. PubMed ID: 17969131
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
